Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. Cancers 2020, 12, 2209
Young Hwa Soung, Heesung Chung, Cecilia Yan, Andrew Fesler, Hyungjin Kim, Eok-Soo Oh, Jingfang Ju, Jun Chung
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research · Circular RNAs in diseases · MicroRNA in disease regulation
In the original publication [1], there was a mistake in Figure 4C and the Supplementary Materials as published. GAPDH blot in Figure 3B was used in GAPDH blot in Figure 4C by mistake. We realized that the GAPDH band for Figure 4C was incorrectly labeled as β-actin in Figure S3. We herein replace the erroneous figure with the correct one. For the Supplementary Materials, we add the full pictures of the Western blots in Figure S3. The corrected GAPDH of Figure 4C and the description of the Supplementary Materials appear below. The authors apologize for any inconvenience caused and state that the scientific conclusions remain unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Supplementary Materials: The following supporting information can be downloaded at: https://www.mdpi.com/2072-6694/12/8/2209/s1, Figure S1: miR-489 mediates anti-proliferative role in TNBC cells; Figure S2: The levels of miR-489 in transfected cells; Figure S3: Full pictures of the Western blots.
The reference list from the paper itself. Each links out to its DOI / PubMed record.